LENZETTO

This brand name is authorized in Croatia, Ecuador, Estonia, Finland, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug LENZETTO contains one active pharmaceutical ingredient (API):

1	Estradiol UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LENZETTO Transdermal spray, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03CA03	Estradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2781-MEE-0517
EE	Ravimiamet	1632169, 1715611, 1849798
ES	Centro de información online de medicamentos de la AEMPS	80608
FI	Lääkealan turvallisuus- ja kehittämiskeskus	053018, 396436
GB	Medicines & Healthcare Products Regulatory Agency	382693, 382698
HR	Agencija za lijekove i medicinske proizvode	HR-H-173338597
IE	Health Products Regulatory Authority	78085
LT	Valstybinė vaistų kontrolės tarnyba	1072022, 1080059
MT	Medicines Authority	MA1031/00101
NL	Z-Index G-Standaard, PRK	167266
PL	Rejestru Produktów Leczniczych	100347999
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62058002, W62058003